Posted by Michael Wonder on 16 Dec 2018
Proposal to harmonise, streamline and transition the Cancer Drug Implementation Advisory Committee to CADTH
14 December 2018 - Providing customised implementation support to decision-makers at all levels of the health system is a key objective of the 2018-2021 CADTH Strategic Plan.
In support of this objective, CADTH and the Canadian Association of Provincial Cancer Agencies (CAPCA) are exploring how some of the implementation advisory functions of the Cancer Drug Implementation Advisory Committee (or CDIAC) can be transferred to CADTH.
CDIAC was created by CAPCA in 2016 to provide advice and recommendations to the provincial cancer agencies on how new cancer drugs could be integrated into existing treatment pathways to support greater sustainability with the introduction of new and often expensive cancer drugs.
